Etrasimod effective induction and maintenance therapy for moderate to severe active ulcerative colitis
USA: A study published in The Lancet has concluded for patients which a history of moderate to severe active ulcerative colitis, Etrasimod is proven to be effective and well tolerated as an induction and maintenance therapy based on the study’s findings. They highlighted the therapeutic option further, saying, Etrasimod is a treatment capable of addressing […] More